INTEGRATED FILING — Other than Banks



General information about company

Scrip code 000000
NSE Symbol SWARAJ
MSEI Symbol NOTLISTED
ISIN INE0GMR01016
Name of Company SWARAJ SUITING LIMITED
Type of company SME
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 30-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 23-May-2025
Description of presentation currency INR (in Actuals)
Reporting Type Half Yearly
Reporting Quarter Yearly
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Manufacturing of fabrics
Start date and time of board meeting 30-May-2025   10:30:00
End date and time of board meeting 30-May-2025   11:55:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? No
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? No
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
(III) Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 2024-09-10
Indicate Company website link for updated RPT policy of the Company https://www.swarajsuiting.com/uploads/reports/RPT.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? Yes
No. of times funds raised during the quarter 6
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
Currently, there is no default of loans


Financial Results — Other than Bank
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Oct-2024 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Revenue From Operations
Revenue from operations 2550609000 4165684000
Other income -5583000 17955000
Total Income 2545026000 4183639000
2 Expenses
(a) Cost of materials consumed 1345468000 2193992000
(b) Purchases of stock-in-trade 452496000 862109000
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade -61127000 -279304000
(d) Employee benefit expense 81855000 161011000
(e) Finance costs 111165000 190578000
(f) Depreciation and amortisation expense 62868000 113592000
(g) Other Expenses
1 Manufacturing Expenses 205475000 428619000
2 Administrative Expesnes 25488000 45963000
3 Selling and Distribution Expenses 17263000 21086000
Total other expenses 248226000 495668000
Total expenses 2240951000 3737646000
3 Profit before exceptional and extraordinary items and tax 304075000 445993000
4 Exceptional items 0 0
5 Profit before extraordinary items and tax 304075000 445993000
6 Extraordinary items 0 0
7 Profit before tax 304075000 445993000
8 Tax Expense
Current tax 38751000 63808000
Deferred tax 30703000 49020000
Total tax expenses 69454000 112828000
9 Net Profit Loss for the period from continuing operations 234621000 333165000
10 Profit (loss) from discontinuing operations before tax 0 0
11 Tax expense of discontinuing operations 0 0
12 Net profit (loss) from discontinuing operation after tax 0 0
13 Profit (loss) for period before minority interest 234621000 333165000
14 Share of profit (loss) of associates
15 Profit (loss) of minority interest
16 Net profit (Loss) for the period 234621000 333165000
17 Details of equity share capital
Paid-up equity share capital 220183000 220183000
Face value of equity share capital 10 10
18 Reserves excluding revaluation reserve 1305340000
19 Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 10.66 15.13
Diluted earnings (loss) per share from continuing and discontinued operations 10.66 15.13
20 Debt equity ratio 0.0128 0.0128
21 Debt service coverage ratio 0.0409 0.0298
22 Interest service coverage ratio 0.0374 0.0334
23 Disclosure of notes on financial results Textual Information(1)


Text Block
Textual Information(1) 1. The above Financial Results were reviewed by the Audit committee and approved by the Board of directors at their respective meeting held on 30.05.2025 2. The Financial Results are prepared in accordance with the Accounting Standards prescribed under Section 133 of the Companies Act, 2013 read with Rule 7 of the Companies (Accounts) Rules, 2014 other recognized Accounting Practices and Policies as applicable. 3. As required under Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, the Statutory Auditors of the company has given their report on the financial results for the half year and year ended 31st March 2025which was also reviwed and approved by the Board of Directors in their meeting held on Friday 30th May 2025. The Auditors Report is unmodified and their are no comments or a remark which needs to be described in the prescribed form. 4. Previous year's figures are re-grouped , re-classified wherever necessary for the better presentation. 5. As our company is listed on SME platform of NSE , it has been exempted from Applicability of IND-AS as per proviso to Rule 4 of Companies( Indian Accounting Standards) Rules, 2015 6. The company has issued share warrant 76,18,000 on 17.07.2023 at Rs. 46.16. All warrant holder's exercised their option upto 31.03.2025 7. There were no investor Complaints pending as on 31-03-2025. 8. The requirement of AS-17 Segment Reporting is not applicable to the Company as it is engaged in single business segment.


Remarks
20 Debt equity ratio
21 Debt service coverage ratio
22 Interest service coverage ratio


Cash flow statement — indirect
A Date of start of reporting period 01-Apr-2024
B Date of end of reporting period 31-Mar-2025
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
1 Statement of cash flows
Cash flows from used in operating activities
Profit before extraordinary items and tax 445993000
2 Adjustments for reconcile profit (loss)
Adjustments to profit (loss)
Adjustments for finance costs 190578000
Adjustments for depreciation and amortisation expense 113592000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for unrealised foreign exchange losses gains 0
Adjustments for dividend income 0
Adjustments for share-based payments 0
Other adjustments for which cash effects are investing or financing cash flow 0
Other adjustments to reconcile profit (loss) -791000
Other adjustments for non-cash items 0
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments to profit (loss) 303379000
3 Adjustments for working capital
Adjustments for decrease (increase) in inventories -491520000
Adjustments for decrease (increase) in trade receivables -346111000
Adjustments for decrease (increase) in other current assets -142244000
Adjustments for increase (decrease) in trade payables 687378000
Adjustments for increase (decrease) in other current liabilities 9351000
Adjustments for provisions 0
Total adjustments for working capital -283146000
Total adjustments for reconcile profit (loss) 20233000
Net cash flows from (used in) operations 466226000
Dividends received 0
Interest paid 0
Interest received -2290000
Income taxes paid (refund) 57900000
Other inflows (outflows) of cash 2607000
Net cash flows from (used in) operating activities before extraordinary items 408643000
Proceeds from extraordinary items 0
Payment for extraordinary items 0
Net cash flows from (used in) operating activities 408643000
4 Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property plant and equipment 0
Purchase of property plant and equipment 1401658000
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Cash advances and loans made to other parties 8232000
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 0
Interest received 2290000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 134305000
Proceeds from government grants 0
Net cash flows from (used in) investing activities before extraordinary items -1273295000
Proceeds from extraordinary items 0
Payment for extraordinary items 0
Net cash flows from (used in) investing activities -1273295000
Cash flows from used in financing activities
Proceeds from issuing shares 131590000
Proceeds from issuing other equity instruments 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 927890000
Repayments of borrowings 0
Dividends paid 0
Interest paid 190578000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) financing activities before extraordinary items 868902000
Proceeds from extraordinary items 0
Payment for extraordinary items 0
Net cash flows from (used in) financing activities 868902000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 4250000
6 Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents 4250000
Cash and cash equivalents cash flow statement at beginning of period 637000
Cash and cash equivalents cash flow statement at end of period 4887000


Statement of Asset and Liabilities
Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Equity and liabilities
1 Shareholders' funds
Share capital 220183000
Reserves and surplus 1305340000
Money received against share warrants 0
Total shareholders' funds 1525523000
2 Share application money pending allotment 0
3 Deferred government grants 0
4 Minority interest
5 Non-current liabilities
Long-term borrowings 1887545000
Deferred tax liabilities (net) 62329000
Foreign currency monetary item translation difference liability account 0
Other long-term liabilities 0
Long-term provisions 14902000
Total non-current liabilities 1964776000
6 Current liabilities
Short-term borrowings 790888000
Trade Payables
(A) Total outstanding dues of micro enterprises and small enterprises 0
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 1315460000
Total Trade payable 1315460000
Other current liabilities 39246000
Short-term provisions 64133000
Total current liabilities 2209727000
Total equity and liabilities 5700026000
Assets
1 Non-current assets
i Property, Plant and Equipment and Intangible assets
Property, Plant and Equipment 2613116000
Producing properties 0
Intangible assets 6854000
Preproducing properties 0
Property, Plant and Equipment capital work-in-progress 127729000
Intangible assets under development or work-in-progress 0
Total Property, Plant and Equipment and Intangible assets 2747699000
ii Non-current investments 26175000
v Deferred tax assets (net) 0
vi Foreign currency monetary item translation difference asset account 0
vii Long-term loans and advances 34577000
viii Other non-current assets 223617000
Total non-current assets 3032068000
Current assets
Current investments 0
Inventories 1395123000
Trade receivables 1008577000
Cash and cash equivalents 4432000
Bank balance other than cash and cash equivalents 455000
Short-term loans and advances 2169000
Other current assets 257202000
Total current assets 2667958000
Total assets 5700026000
Disclosure of notes on assets and liabilities


Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results
Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Oct-2024 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether results are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets
Net Segment Asset
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities
Net Segment Liabilities
Disclosure of notes on segments




Details of Impact of Audit Qualification
Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 KARP AND CO Yes 30-Jun-2025


Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (1)
Mode of Fund Raising Preferential Issues
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds 23-Dec-2024
Amount Raised 6058000
Report filed for Quarter ended 31-Mar-2025
Monitoring Agency Not Applicable
Monitoring Agency Name, if applicable
Is there a Deviation / Variation in use of funds raised No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation NA
Comments of the Audit Committee after review NO COMMENTS
Comments of the auditors, if any NO COMMENTS
Sr. Original Object Modified Object, if any Original Allocation Modified allocation, if any Funds Utilised Amount of Deviation/Variation for the quarter according to applicable object Remarks if any
1 Working Capital requirement and business expansion NA 6058000 0 6058000 0 During the half year ended on March 31 2025 the Company fully utilised the fund received from allotement of 175000 equity shares on 23 December 2024 pursuant to warrant converfsion with exercise price Rs.34.62


Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (2)
Mode of Fund Raising Preferential Issues
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds 07-Jan-2025
Amount Raised 29946000
Report filed for Quarter ended 31-Mar-2025
Monitoring Agency Not Applicable
Monitoring Agency Name, if applicable
Is there a Deviation / Variation in use of funds raised No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation NA
Comments of the Audit Committee after review NO COMMENTS
Comments of the auditors, if any NO COMMENTS
Sr. Original Object Modified Object, if any Original Allocation Modified allocation, if any Funds Utilised Amount of Deviation/Variation for the quarter according to applicable object Remarks if any
1 Working Capital requirement and business expansion NA 29946000 0 29946000 0 During the half year ended on March 31 2025 the Company fully utilised the fund received from allotement of 865000 equity shares on 7 January 2025 pursuant to warrant converfsion with exercise price Rs.34.62


Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (3)
Mode of Fund Raising Preferential Issues
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds 08-Jan-2025
Amount Raised 20772000
Report filed for Quarter ended 31-Mar-2025
Monitoring Agency Not Applicable
Monitoring Agency Name, if applicable
Is there a Deviation / Variation in use of funds raised No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation NA
Comments of the Audit Committee after review NO COMMENTS
Comments of the auditors, if any NO COMMENTS
Sr. Original Object Modified Object, if any Original Allocation Modified allocation, if any Funds Utilised Amount of Deviation/Variation for the quarter according to applicable object Remarks if any
1 Working Capital requirement and business expansion NA 20772000 0 20772000 0 During the half year ended on March 31 2025 the Company fully utilised the fund received from allotement of 600000 equity shares on 8 January 2025 pursuant to warrant converfsion with exercise price Rs.34.62


Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (4)
Mode of Fund Raising Preferential Issues
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds 14-Jan-2025
Amount Raised 17310000
Report filed for Quarter ended 31-Mar-2025
Monitoring Agency Not Applicable
Monitoring Agency Name, if applicable
Is there a Deviation / Variation in use of funds raised No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation NA
Comments of the Audit Committee after review NO COMMENTS
Comments of the auditors, if any NO COMMENTS
Sr. Original Object Modified Object, if any Original Allocation Modified allocation, if any Funds Utilised Amount of Deviation/Variation for the quarter according to applicable object Remarks if any
1 Working Capital requirement and business expansion NA 17310000 0 17310000 0 During the half year ended on March 31 2025 the Company fully utilised the fund received from allotement of 500000 equity shares on 14 January 2025 pursuant to warrant converfsion with exercise price Rs.34.62


Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (5)
Mode of Fund Raising Preferential Issues
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds 15-Jan-2025
Amount Raised 39709000
Report filed for Quarter ended 31-Mar-2025
Monitoring Agency Not Applicable
Monitoring Agency Name, if applicable
Is there a Deviation / Variation in use of funds raised No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation NA
Comments of the Audit Committee after review NO COMMENTS
Comments of the auditors, if any NO COMMENTS
Sr. Original Object Modified Object, if any Original Allocation Modified allocation, if any Funds Utilised Amount of Deviation/Variation for the quarter according to applicable object Remarks if any
1 Working Capital requirement and business expansion NA 39709000 0 39709000 0 During the half year ended on March 31 2025 the Company fully utilised the fund received from allotement of 1147000 equity shares on 15 January 2025 pursuant to warrant converfsion with exercise price Rs.34.62


Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (6)
Mode of Fund Raising Preferential Issues
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds 16-Jan-2025
Amount Raised 138000
Report filed for Quarter ended 31-Mar-2025
Monitoring Agency Not Applicable
Monitoring Agency Name, if applicable
Is there a Deviation / Variation in use of funds raised No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation NA
Comments of the Audit Committee after review NO COMMENTS
Comments of the auditors, if any NO COMMENTS
Sr. Original Object Modified Object, if any Original Allocation Modified allocation, if any Funds Utilised Amount of Deviation/Variation for the quarter according to applicable object Remarks if any
1 Working Capital requirement and business expansion NA 138000 0 138000 0 During the half year ended on March 31 2025 the Company fully utilised the fund received from allotement of 4000 equity shares on 16 January 2025 pursuant to warrant converfsion with exercise price Rs.34.62


Signatory Details
Name of signatory MOHAMMED SABIR KHAN
Designation of person Managing Director
Place BHILWARA
Date 30-May-2025


Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity /subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
Total value of transaction during the reporting period